Novocure is a global oncology company developing a proprietary platform technology called Tumor Treating Fields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The science of Tumor Treating Fields may have the potential to treat a range of solid tumor cancers. Novocure’s commercialized product is approved for the treatment of adult patients with glioblastoma multiforme.
For additional information about the company, please visit www.novocure.com or follow us at www.twitter.com/novocure.